ABSTRACT Objective: To evaluate the nutritional status and caloric and protein intake during the hospitalization of patients undergoing hematopoietic stem cell transplantation. Methods: A retrospective study was performed based on clinical and nutritional data of patients undergoing autologous and allogeneic hematopoietic stem cell transplantation from March 2015 to March 2017. The mean caloric and protein intake were evaluated in three different intervals (P1: from admission to the day before transplantation, P2: from the transplantation day to the day before engraftment, P3: from the engraftment day to the day of hospital discharge). Body mass index, weight loss, gastrointestinal symptoms and use of nutritional therapy were also evaluated. Results: Thirty-five patients were included in this study (25 autologous and ten allogeneic). The majority (62.6%) were overweight at admission. The median and percentage weight loss were 3.2 kg and 4.6%, respectively. A nutritional supplement was provided to 33 patients for a median of nine days. The most prevalent gastrointestinal symptoms were nausea (91.4%), vomiting (88.6%) and diarrhea (80%). The mean caloric and protein intake and adequacy of patients were 1569.0 ± 443.3 Kcal (73.6 ± 22.1%) and 66 ± 22.8 g (61.9 ± 20%), respectively. The allogeneic group presented lower intake and caloric and protein adequacy throughout hospitalization, in particular in P2, compared to the autologous patients. Conclusion: The patients presented deterioration of nutritional status during hospitalization with the reduction in food intake being greater in patients submitted to allogeneic transplantation.

Objetivo Embora existam programas efetivos para tratamento da obesidade, são grandes as taxas de abandono. O objetivo deste trabalho foi investigar o estágio motivacional em que se encontravam pacientes com sobrepeso ou obesidade I e II atendidos em ambulatório de Nutrição e seus fatores associados. Métodos Trata-se de um estudo transversal, com amostragem por conveniência, em que foram coletadas informações da história clínica, antropometria, compulsão alimentar (BES – Binge Eating Scale) e motivação para o tratamento (URICA – University of Rhode Island Change Assessment Scale). Resultados Dos 48 avaliados, 29,2% encontravam-se em pré-contemplação, 41,7%, em contemplação e 29,2%, em ação. Quem procurou tratamento para controle de alguma comorbidade além da perda de peso teve maior escore de prontidão (p = 0,024). Motivação não foi relacionada ao estado nutricional nem à tentativa anterior de perda de peso, mas relacionou-se à orientação profissional anterior (p = 0,005). Dos 26,8% que apresentavam sintomatologia moderada ou grave para compulsão alimentar, 90,9% estavam em contemplação, com diferença significativa quanto à pré-contemplação (p = 0,001) e à ação (p = 0,02). Conclusão Esses resultados sugerem que parte dos indivíduos que procuram tratamento para perda de peso não o faz com a motivação necessária e que, se o aconselhamento profissional quanto à importância da perda de peso ocorresse antes que patologias associadas à obesidade se instalassem, indivíduos mais motivados poderiam procurar tratamento e evitar tais complicações.

Objective Although there are effective programs for treating obesity, are large dropout rates. The aim of this study was to investigate the motivational stage in patients who were overweight or obesity I and II, in an outpatient clinic nutrition, and its associated factors. Methods It is a cross-sectional study with convenience sampling, in which information from the clinical history, anthropometry, binge eating (BES – Binge Eating Scale) and motivation for treatment (URICA – University of Rhode Island Change Assessment Scale) were collected. Results Of the 48 evaluated, 29.2% were in precontemplation stage, 41.7% were in contemplation stage and 29.2% were in action stage. Who sought treatment for comorbidity control besides the weight loss had greater readiness score (p = 0.024). Motivation was not related to nutritional status, nor the previous attempt at weight loss, but was related to the previous professional guidance (p = 0.005). Among 26.8% had moderate or severe symptoms for binge eating, 90.9% were in contemplation, with a significant difference in pre-contemplation (p = 0.001) and action (p = 0.02). Conclusion These results suggest that individuals who seek treatment for weight loss do not make it with the necessary motivation, and that if professional advice on the weight loss importance occurred before the associated with obesity pathologies were installed, more motivated individuals could seek treating and preventing these complications.

OBJETIVO: Avaliar o perfil bioquímico e nutricional de fumantes em tratamento para a cessação tabágica e sua associação com parâmetros antropométricos. MÉTODOS: Trata-se de um estudo transversal com amostra de conveniência. Adultos fumantes foram avaliados no início do tratamento no Centro Interdisciplinar de Pesquisa e Intervenção em Tabagismo do Hospital Universitário da Universidade Federal de Juiz de Fora (CIPIT/HU-UFJF). Foram avaliados o índice de massa corporal (IMC), índice de conicidade (IC), circunferência da cintura (CC), percentual de gordura corporal (%GC), glicemia de jejum, cortisol, insulina, colesterol total (TC), colesterol LDL-c, HDL-c, triglicéridos (TG) e síndrome metabólica (SM). RESULTADOS: A maioria dos participantes possuía SM e alto risco cardiovascular. A glicemia de jejum estava alterada em 30,4%. Houve correlação positiva significativa entre IMC e CC (r = 0,90; p = 0,0001), %GC (r = 0,79; p = 0,0001), IC (r = 0,65; p = 0,0001), glicemia (r = 0,42; p = 0,04) e TG (r = 0,47; p = 0,002). O IC também apresentou correlação positiva com insulina (r = 0,6; p = 0,001), glicemia (r = 0,55; p = 0,007), TG (r = 0,54; p = 0,008) e %GC (r = 0,43; p = 0,004). Pacientes com maior tempo de tabagismo tiveram maior risco de desenvolver SM (O = 9,6; p = 0,016). CONCLUSÃO: Os fumantes avaliados tiveram maior risco de desenvolver SM, especialmente aqueles que fumavam por mais tempo, requerendo urgência para a cessação tabágica.

OBJECTIVE: To evaluate the biochemical and nutritional status of smokers in treatment for smoking cessation and its association with anthropometric parameters. METHODS: This is a cross-sectional study with convenience sample. Adult smokers were assessed at the start of treatment in the Interdisciplinary Center for Tobacco Research and Intervention of the University Hospital of the Federal University of Juiz de Fora (CIPIT/HU-UFJF). We evaluated the body mass index (BMI), conicity index (CI); waist circumference (WC), percentage of body fat (%BF), fasting glycemia, cortisol, insulin, total cholesterol (TC), LDL-c, HDL-c, triglycerides (TG) and metabolic syndrome (MS). RESULTS: Most participants (52.2%) had MS and high cardiovascular risk. The fasting glycemia was abnormal in 30.4%. There was a significant positive correlation between BMI and WC (r = 0.90; p = 0.0001), %BF (r = 0.79; p = 0.0001), CI (r = 0.65; p = 0.0001), glycemia (r = 0.42; p = 0.04) and TG (r = 0.47; p = 0.002). The CI presented positive correction with insulin (r = 0.60; p = 0.001), glycemia (r = 0.55; p = 0.007), TG (r = 0.54; p = 0.008) and %BF (r = 0.43; p = 0.004). Patients with longer duration of smoking had a higher risk of developing MS (OR = 9.6, p = 0.016). CONCLUSION: The smokers evaluated had increased risk for developing MS, especially those with longer duration of smoking, requiring urgent smoking cessation.